$ICAD News

Last published 1y ago

1y agoBWAY HYFT ICAD AMCSMindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth StrategyBusiness WireMindWalk Holdings Corp.™ ("MindWalk," "Company," "we" or "us") (NASDAQ:HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief Financial Officer (CFO),
1y agoICAD RDNTRadNet's Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCADGlobeNewswireAcquisition contributes iCAD's commercial, technology, and regulatory capabilitiesThe acquisition positions DeepHealth with an industry-leading suite of AI-powered breast cancer image interpretation and workflow
1y agoICADiCAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote "FOR" Proposed Acquisition by RadNet, Inc.GlobeNewswireNASHUA, N.H., July 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company"), a global leader in clinically proven AI-powered cancer detection solutions, today announced that leading independent
1y agoICADiCAD Reports Financial Results for First Quarter Ended March 31, 2025GlobeNewswireNASHUA, N.H., May 13, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven
1y agoRDNT ICAD MSFTBehind the FDA's AI Push: A Growing Class of Public Healthcare InnovatorsPR NewswireUSA News Group News Commentary – In a clear sign of growing confidence in artificial intelligence (AI) for healthcare, the U.S. Food and Drug...
1y agoPHG RDNT ICADClinical AI Platforms Expand Globally Amid Regulatory and Market TailwindsPR NewswireAcross the western healthcare landscape, artificial intelligence (AI) is being increasingly adopted to simplify authorizations and cut through layers ...
1y agoICADiCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft's Precision Imaging Network (PIN)GlobeNewswireNASHUA, N.H., April 29, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company"), a global leader in clinically proven AI-powered cancer detection solutions, announced today a collaboration with
1y agoICAD RDNTRadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast CancerGlobeNewswireThe acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancerThe transaction is expected to add to RadNet's
1y agoICADiCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial OfficerGlobeNewswireNASHUA, N.H., April 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven
1y agoICADiCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024GlobeNewswireNASHUA, N.H., March 19, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven
1y agoICADiCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025GlobeNewswireNASHUA, N.H., March 11, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the fourth
1y agoICADiCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North AmericaGlobeNewswireNASHUA, N.H. and TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and RamSoft®, a global leader in cloud-based
1y agoICADKoios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025GlobeNewswireNASHUA, N.H. and CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and Koios Medical, a leader in AI-driven ultrasound
1y agoICADiCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025GlobeNewswireNASHUA, N.H., Feb. 19, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven
1y agoICADiCAD Pre-Announces Estimated Q4 2024 RevenueGlobeNewswireiCAD to Participate in the BTIG at Snowbird:12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference NASHUA, N.H., Jan. 27, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the
1y agoICADSABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse PopulationsGlobeNewswireNASHUA, N.H., Dec. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader in clinically proven AI-powered cancer detection solutions, announced today that four novel AI-driven
1y agoICADCORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024GlobeNewswireNASHUA, N.H., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Further to a release issued under the same headline on November 26, 2024 13:00 ET by iCAD, Inc., the headline and fourth paragraph have been updated to acknowledge a
1y agoICADiCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024GlobeNewswireNASHUA, N.H., Nov. 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company"), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast
1y agoICADiCAD, Inc. (ICAD) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
1y agoICADiCAD Reports Financial Results for Third Quarter Ended September 30, 2024GlobeNewswireNASHUA, N.H., Nov. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven
1y agoICADiCAD's ProFound Detection Version 4.0 Gains FDA ClearanceGlobeNewswireNASHUA, N.H., Nov. 12, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader in clinically proven AI-powered cancer detection solutions, announced today that its ProFound Detection
2y agoICADiCAD to Attend 15th Annual Craig-Hallum Alpha Select ConferenceGlobeNewswireNASHUA, N.H., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast
2y agoICADiCAD to Report Third Quarter 2024 Financial Results on November 13, 2024GlobeNewswireNASHUA, N.H., Nov. 05, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the third
2y agoICADiCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024GlobeNewswireNASHUA, N.H. and PARIS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader in clinically proven AI-powered cancer detection solutions, today announced its participation
2y agoICADiCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024GlobeNewswireNASHUA, N.H., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered
2y agoICADiCAD, Inc. (ICAD) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoICADiCAD Reports Financial Results for Second Quarter Ended June 30, 2024GlobeNewswireNASHUA, N.H., Aug. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast
2y agoICADiCAD to Report Second Quarter 2024 Financial Results on August 13, 2024GlobeNewswireNASHUA, N.H., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the second
2y agoICADiCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered MammographyGlobeNewswireNASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C., July 29, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced a strategic
2y agoICADiCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024GlobeNewswireNASHUA, N.H., June 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, today announced it will highlight new research demonstrating the
2y agoICADiCAD to Participate in the MedInvest MedTech, AI & Digital Health ConferenceGlobeNewswireNASHUA, N.H., June 04, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions,
2y agoICADiCAD, Inc. (ICAD) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoICADiCAD Reports Financial Results for First Quarter Ended March 31, 2024GlobeNewswireNASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, today
2y agoICADUPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024GlobeNewswireNASHUA, N.H., May 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the first
2y agoICADiCAD to Report First Quarter 2024 Financial Results on May 15, 2024GlobeNewswireNASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the first
2y agoICADiCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual SymposiumGlobeNewswireProFound Cloud, powered by Google Cloud architecture and Google's Health AI innovations, redefines accessibility to critical insights, empowering radiologists in early breast cancer detectionNew partnership with Densitas
2y agoICADiCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk EvaluationGlobeNewswireProvides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast density assessment, and risk evaluationExpands access to iCAD's
2y agoICADiCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology MeetingGlobeNewswireNASHUA, N.H., April 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today that new data indicates its AI-powered solution
2y agoICADiCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)GlobeNewswireNASHUA, N.H., April 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, is proud to announce a philanthropic global health collaboration
2y agoICADiCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise ScaleGlobeNewswireNASHUA, N.H., April 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced commercial availability of ProFound Cloud. The
2y agoICADiCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for RadiologistsGlobeNewswireNASHUA, N.H., March 19, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and
2y agoICADiCAD, Inc. (ICAD) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
2y agoICADiCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial ResultsGlobeNewswireAnnual Recurring Revenue of $8.7 million, an increase of 15% year-over-yearFull-Year Operating Cash Flow ($5) million vs. ($12.8) million prior yearYear ending cash balance of $21.7M NASHUA, N.H., March 12, 2024
2y agoICADiCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform OfferingsGlobeNewswireClinical evidence demonstrates ProFound Detection's AI may help reduce breast interval cancer (IC) rates and decrease recall rates without additional false negatives Findings reveal substantially lower radiology reading
2y agoICADiCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)GlobeNewswireNASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader in providing clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer
2y agoICADiCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024GlobeNewswireNASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and
2y agoICADiCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewswireNASHUA, N.H., Feb. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and
2y agoICADiCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board MemberGlobeNewswireNASHUA, N.H., Jan. 30, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and
2y agoICADiCAD Expands Executive Sales Leadership Team as Business GrowsGlobeNewswireNASHUA, N.H., Dec. 18, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced the expansion of its sales leadership with the
2y agoICADiCAD's AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE HealthcareGlobeNewswireKey apps from the iCAD Breast Health Suite are now integrated with GE HealthCare's new MyBreastAI Suite*AI applications streamline workflow and support clinicians in delivering more personalized breast care,